The commissioning of Lurasidone is accepted in Devon for the management of schizophrenia in adults where patients have not responded to, or not tolerated, separate trials of amisulpride AND aripiprazole; OR QTc prolongation has been identified AND the patient has previously not responded to, or not tolerated, aripiprazole.
| Filename: | Lurasidone for schizophrenia in adults |
| Filetype: | |
| Filesize: | 102.34 KB |
| Date uploaded: | 29th September 2023 |
| Date updated: | 29th September 2023 |
